Why the study?
The increasing prevalence of CVDs particularly IHD, coupled with advanced technologies, imposes a major financial burden on healthcare systems.
The substantial financial burden of ischemic heart disease on the healthcare system in Iran underscores the critical need for policy actions focused on lifestyle modification and primary prevention.
The majority of cardiovascular procedure costs are attributable to diagnosing and treating ischemic heart disease (IHD). Consequently, the increasing prevalence of CVDs particularly IHD coupled with the use of advanced technologies, imposes a significant financial burden on the healthcare system. This underscores the critical need for policy actions focused on lifestyle modification and primary prevention. Such measures are essential to curb rising costs and ensure healthcare system sustainability.
No takes yet. Share an insight, caveat, or question.
Rezayatmand et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: